ginsenoside rh2 has been researched along with tetrodotoxin in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (tetrodotoxin) | Trials (tetrodotoxin) | Recent Studies (post-2010) (tetrodotoxin) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 12,992 | 11 | 1,477 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | tetrodotoxin (IC50) |
|---|---|---|---|
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 0.0186 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, Y; Nicholson, RA | 1 |
1 other study(ies) available for ginsenoside rh2 and tetrodotoxin
| Article | Year |
|---|---|
20(S)-protopanaxadiol and the ginsenoside Rh2 inhibit Na+ channel-activated depolarization and Na+ channel-dependent amino acid neurotransmitter release in synaptic fractions isolated from mammalian brain.
Topics: Animals; Brain; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Ginsenosides; Glutamic Acid; In Vitro Techniques; Male; Membrane Potentials; Mice; Sapogenins; Sodium Channel Blockers; Sodium Channels; Synaptosomes; Tetrodotoxin; Triterpenes; Veratridine | 2008 |